ESC Premium Access

Efficacy and safety of fondaparinux versus unfractionated heparin in patients hospitalised with severe COVID-19 pneumonia and coagulopathy: a randomised, open-label clinical trial

Topic: Cardiovascular Pharmacotherapy

Presentation

About the speaker

Doctor Liemena Harold Adrian

Medical Faculty Brawijaya University, Malang (Indonesia)
0 follower

4 more presentations in this session

The role of STEMI integrated networking system based on tele-cardiology for reducing ischemic time and crossing wire time delayed during COVID 19 pandemic

Speaker: Mr M. Rizki Fadlan (Malang, ID)

Thumbnail

Symptomatology, prognosis and clinical findings of myocarditis as an adverse event of COVID-19 mRNA vaccine: a systematic review

Speaker: Doctor A. Jaiswal (New Delhi, IN)

Thumbnail

Early impact of COVID-19 pandemic on heart transplant volumes in Asia and Oceania: results from the Global Observatory on Donation and Transplantation (GODT)

Speaker: Doctor Y. Manla (Abu Dhabi, AE)

Thumbnail

Effectiveness of a home-based cardiovascular disease prevention program during the COVID-19 pandemic

Speaker: Doctor P. Chockalingam (Chennai, IN)

Thumbnail

Access the full session

Live Abstracts - COVID

Speakers: Doctor L. Adrian, Mr M. Rizki Fadlan, Doctor A. Jaiswal, Doctor Y. Manla, Doctor P. Chockalingam
Thumbnail

About the event

Image

ESC Asia with APSC & AFC 2021

2 December - 4 December 2021

Sessions Presentations

This platform is supported by

logo Novo Nordisk